Reported Feb 16, 2022 · Terminated
HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab…
ULTRAtab Laboratories, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: ULTRAtab Laboratories, Inc. · 50 Toc Dr · Highland, NY · 12528-1506
Is this the product you have?
HPC Tablet (Acetaminophen 110 mgAspirin 162 mgCaffeine 32.4 mgSalicylamide 152 mg) Bulk ContainerULTRAtab LaboratoriesIncHighlandNY NDC 62969-242-00
- Lot codes and dates
4 of 4 products
Products covered by this recall Model / number Product as published — L242SRC Bulk Lot: 18K086, 18L009, 18L050, 18L083, 18M025, 18M073, 18M098, 19A010, 19A084, 19A105, 19A107 L242LBulk Lot: 19H014 L242PABulk Lot: 18F072, 18L119, 19A067, 19G043 L242NBulk Lot: 19H040 - Amount recalled
- 50,585,623 tablets
This recall covers 42 products
The agency filed one notice per product. You are reading one of them; the other 41 are below.
29 more are in the archive.
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new ULTRAtab Laboratories, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.